The DOI matches its Crossref record, with a small difference in title or year; 251 of the 252 references it cites were found in a registry or an index.
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Open accessAbstract
Hypertrophic cardiomyopathy (HCM) is a genetic disorder that is characterized by left ventricular hypertrophy unexplained by secondary causes and a nondilated left ventricle with preserved or increased ejection fraction. It is commonly asymmetrical with the most severe hypertrophy involving the basal interventricular septum. Left ventricular outflow tract obstruction is present at rest in about one third of the patients and can be provoked in another third. The histological features of HCM include myocyte hypertrophy and disarray, as well as interstitial fibrosis. The hypertrophy is also frequently associated with left ventricular diastolic dysfunction. In the majority of patients, HCM has a relatively benign course. However, HCM is also an important cause of sudden cardiac death, particularly in adolescents and young adults. Nonsustained ventricular tachycardia, syncope, a family history of sudden cardiac death, and severe cardiac hypertrophy are major risk factors for sudden cardiac death. This complication can usually be averted by implantation of a cardioverter-defibrillator in appropriate high-risk patients. Atrial fibrillation is also a common complication and is not well tolerated. Mutations in over a dozen genes encoding sarcomere-associated proteins cause HCM. MYH7 and MYBPC3 , encoding β-myosin heavy chain and myosin-binding protein C, respectively, are the 2 most common genes involved, together accounting for ≈50% of the HCM families. In ≈40% of HCM patients, the causal genes remain to be identified. Mutations in genes responsible for storage diseases also cause a phenotype resembling HCM (genocopy or phenocopy). The routine applications of genetic testing and preclinical identification of family members represents an important advance. The genetic discoveries have enhanced understanding of the molecular pathogenesis of HCM and have stimulated efforts designed to identify new therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This clinical variability can, in part, be explained by the influence of modifiable cardiometabolic risk factors, such as obesity, diabetes, and hypertension [6].”
From Association of GLP-1 receptor agonist use with cardiovascular outcomes in patients with non-obstructive hypertrophic cardiomyopathy (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“Hypertrophic cardiomyopathy (HCM) is characterized by cardiac hypertrophy, a non-dilated left ventricle (LV), and a normal or increased EF.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults
Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T., & Bild, D. E. (1995) · Circulation · doi:10.1161/01.cir.92.4.785 · Cited by 2,274
Sudden Deaths in Young Competitive Athletes
Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009) · Circulation · doi:10.1161/circulationaha.108.804617 · Cited by 2,099
Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles
Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
Semsarian, C., Ingles, J., Maron, M. S., & Maron, B. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.019 · Cited by 1,405
Geisterfer-Lowrance, A. A. T., Kass, S., Tanigawa, G., Vosberg, H.-P., McKenna, W., Seidman, C. E., & Seidman, J. G. (1990) · Cell · doi:10.1016/0092-8674(90)90274-i · Cited by 1,380
Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066323.15244.54 · Cited by 1,276
O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht439 · Cited by 1,251
Research works printed but not linked: 2
- 10.1161/01.CIR.104.3.317 · DOI
- BROCK R. Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis). Guys Hosp Rep. 1959;108:126–143.
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Kolonay, D., Grueter, C. E., & Baskin, K. K. (2025) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2025.100456 · Cited by 3
Wang, Y., Wang, Z., Sun, N., Yin, J., Chen, Y., Wang, C., & Yang, S. (2025) · Gene · doi:10.1016/j.gene.2025.149597 · Cited by 2
Hyperpolarized-MRI in Hypertrophic Cardiomyopathy: A Narrative Review
Malik, A., Kundur, S. P., & Sivalokanathan, S. (2025) · Clinical Medicine Insights Cardiology · doi:10.1177/11795468251369234 · Cited by 2
Roeck, F. D., Lahaye, F., Gevaert, A. B., Paep, R. D., & Craenenbroeck, E. M. V. (2025) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytaf490 · Cited by 2
Danshen ( Salvia miltiorhiza ) inhibits Leu27 IGF‐II ‐induced hypertrophy in H9c2 cells
Ho, T., Wu, H. C., Kumar, V. B., Kuo, W., Weng, Y., Yeh, Y., Mahalakshmi, B., Day, C. H., Li, C., & Huang, C. (2020) · Environmental Toxicology · doi:10.1002/tox.22940 · Cited by 2
Nfonsam, L. E., Ordorica, S., Ghani, M., Potter, R., Schaffer, A., Daoud, H., Vasli, N., Chisholm, C., Sinclair‐Bourque, E., McGowan‐Jordan, J., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105443 · Cited by 2
Prenatal Diagnosis and Preimplantation Genetic Testing for Inherited Cardiac Diseases
Nannenberg, E. A., & Arens, Y. H. J. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-45457-9_27 · Cited by 2
Anghel, L., Stătescu, C., Șerban, I.-L., Maranducă, M. A., Butcovan, D., Clément, A., Bostan, M., & Sascău, R. A. (2020) · Diagnostics · doi:10.3390/diagnostics10090719 · Cited by 2
Heart Failure as a Consequence of Hypertrophic Cardiomyopathy
Marian, A. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00023-5 · Cited by 2
Self-citationOmae, T., Candiotti, A., Koh, K., Kumemura, M., Sakuraba, S., Iwatsubo, C., Yasui, M., & Katsuda, Y. (2021) · 循環制御 · doi:10.11312/ccm.42.17 · Cited by 2
Isolated extreme right ventricular hypertrophy: A case report
Shako, D., Kawasaki, T., Yamano, M., & Matoba, S. (2021) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2021.10.002 · Cited by 2
Gore, S., & Swami, S. Y. (2022) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_285_19 · Cited by 2
Lü, J., Fan, Z.-X., Li, Y., Wang, Z., Ma, L., Yuan, B.-Y., Yang, T., Liu, P.-J., & Liu, G.-Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1054199 · Cited by 2
Genomics in practice - a review of inherited cardiac conditions
Loong, S. S. E., Gan, L. H., Lim, Y. C., Ng, M. M. Q., Wang, Y., Koo, S. H., Chew, N., Yeo, C., Tan, V. H., Leong, K. M. W., et al. (2023) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2022.20 · Cited by 2
Novel insights on GTPBP3‐associated hypertrophic cardiomyopathy
Angelova, P., Velchev, V., Stoyanov, N., Atemin, S., Todorov, T., Tourtourikov, I., Mitev, V., & Тодорова, А. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63205 · Cited by 2
Ilonze, O. J., Hicks, A. J., Atanda, B., Abdou, M. A. H., Onyekwelu, C., Chukwu, E. O., Karaye, K. M., Katibi, I. A., Ogah, O. S., Emerole, O., et al. (2023) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2023-016 · Cited by 2
Neonatal hypertrophic cardiomyopathy with dyspnoea as the first symptom: a case report
Li, X., Hong, S.-J., Hong, H., Zhang, Z., & Li, J. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1295539 · Cited by 3
Almani, M. U., Talha, K. M., Khan, L. A., Hameed, I., Asad, Z. U. A., Fudim, M., Krasuski, R. A., & Khan, M. S. (2024) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2024.04.009 · Cited by 2
Yang, J., Wang, L., Sun, T., Guo, Q., Liu, F., & Zhou, Y. (2019) · Perfusion · doi:10.1177/0267659119883996 · Cited by 2
van den Brink, L., Grandela, C., Mummery, C. L., & Davis, R. P. (2019) · Cited by 2
Vaideeswar, P., Tyagi, S., Singaravel, S., & Marathe, S. P. (2021) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_845_20 · Cited by 2
Variation p.R1045H in MYH7 correlated with hypertrophic cardiomyopathy in a Chinese pedigree
Zhang, Y., Shang, Y., Liu, L., Ding, X., Wu, H., Li, L., & Pang, M. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01046-2 · Cited by 2
Lu, H., Zhang, J., Chen, Y. E., & Garcia-Barrio, M. T. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07175-1 · Cited by 2
Novel Myosin-Based Therapies in Hypertrophic Cardiomyopathy
Sewanan, L. R., & Jacoby, D. L. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00921-6 · Cited by 2
A new look into hypertrophic cardiomyopathy based on clinical evidence
de Oliveira, G. M. M. (2018) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2018.01.001 · Cited by 2
Ingles, J., & Semsarian, C. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.002112 · Cited by 2
Pathology of endomyocardial biopsy
d’Amati, G., Cerbelli, B., & Giordano, C. (2018) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2018.10.001 · Cited by 2
Frangogiannis, N. G. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.09.009 · Cited by 2
Hypertrophic cardiomyopathy: modern aspects of pharmacologic treatment
Gudkova, A. Y., Streltsova, A. A., & Kostareva, A. A. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.09.000137 · Cited by 2
Lee, S., Roest, A. S. V., Blair, C. A., Kao, K. Y., Bremner, S. B., Childers, M. C., Pathak, D., Heinrich, P., Lee, D. C., Chirikian, O., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.08.544276 · Cited by 2
Deciphering epistatic genetic regulation of cardiac hypertrophyPreprint
Wang, Q., Tang, T. M., Youlton, M., Weldy, C. S., Kenney, A., Ronen, O., Hughes, J. W., Chin, E. T., Sutton, S. C., Agarwal, A., et al. (2023) · medRxiv · doi:10.1101/2023.11.06.23297858 · Cited by 2
Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
Marine, J. E., & Vasquez, N. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100900 · Cited by 2
An Optimization Framework to Personalize Passive Cardiac MechanicsPreprint
Shi, L. T., Chen, I. Y., Takayama, H., & Vedula, V. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4783034 · Cited by 2
Dutta, D., Kim, Y., Ho, C. Y., SHaRe Investigators, Seidman, J. G., Seidman, C. E., Craig, R. W., & Padrón, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.03.680256 · Cited by 2
Thoracic Pain: Clinical Features
Cannata, A. N., Artico, J., Paris, V. D., Cristallini, J., Gentile, P., Naso, P., Ortis, B., Fabris, E., & Sinagra, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-99822-0_9 · Cited by 1
Adeniran, I., Wadee, H., & Degens, H. (2024) · BioMed Research International · doi:10.1155/2024/6160554 · Cited by 1
Shinde, V., Thakkar, D., Sharma, V., & Mavudelli, S. J. (2024) · Cureus · doi:10.7759/cureus.66809 · Cited by 1
Revolutionizing Cardiac Care: The Role of Gene Therapy in Treating Cardiomyopathy
Desai, D. H., Maheta, D., Agrawal, S. P., Patel, M., Frishman, W. H., & Aronow, W. S. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000792 · Cited by 1
Lien, N. T. K., Tung, N. V., Tu, L. T., Vân, Đ. T. H., Vu, Q. N., Lan, N. N., Hiển, N. T., Thanh, L. T., Đức, N. M., & Hoàng, N. H. (2024) · Vietnam Journal of Biotechnology · doi:10.15625/vjbt-19499 · Cited by 2
Mazur, M. M., Dowling, R. D., Bhat, G., Rubio, A. C., & Eisen, H. J. (2024) · ASAIO Journal · doi:10.1097/mat.0000000000002347 · Cited by 1
Xu, Q., Li, R., Liu, Y., Chen, Y., Luo, A., Wei, X., & Yao, W. (2024) · Journal of Anesthesia and Translational Medicine · doi:10.1016/j.jatmed.2024.10.002 · Cited by 1
Pavlova, S. V., Shulgina, A. E., Minina, J. M., Zakian, S. M., & Dementyeva, E. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312900 · Cited by 1
MYH7 hypertrophic cardiomyopathy with heart block presenting with papilledema: A case report
Dhillon, R., Nizami, Z., & Nair, A. S. (2024) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2024.101798 · Cited by 1
Four cardiomyopathy patients with a heterozygous DSG2 p.Arg119Ter variant
Sumida, T., Ogawa, S., Higo, S., Kuramoto, Y., Eto, R., Ikeda, Y., Sun, C., Li, J., Liu, L., Tabata, T., et al. (2024) · Human Genome Variation · doi:10.1038/s41439-024-00304-w · Cited by 1
Hurst, M. A., Zema, C., Krause, T., Sandler, B. C., Lemmer, T., Noon, K. M., Alexander, D., & Osman, F. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080142 · Cited by 1
Hamidi, J., Hanel, Y., Dittmann, S., Gerding, W. M., Nguyen, H. P., Klingel, K., & Schulze‐Bahr, E. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1462523 · Cited by 1
The contribution of genetics to the understanding and management of cardiomyopathies: Part 1
Cardoso, I., Nunes, S. G., Bras, P. G., Viegas, J., Antunes, M. M., Ferreira, A., Almeida, I., Custódio, I., Trigo, C., Laranjo, S. M., et al. (2025) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2024.11.012 · Cited by 1
Ruiz‐Velasco, A., Jouve, C., Deshayes, L., Kohlhaas, M., Maack, C., & Hulot, J. (2026) · Pediatric Research · doi:10.1038/s41390-026-05208-9 · Cited by 1
Pugsley, M. K., Hwee, D. T., Winters, B. R., Wang, J., Chin, E. R., Morgan, B. P., & Malik, F. I. (2025) · International Journal of Toxicology · doi:10.1177/10915818251326466 · Cited by 1
Petranović, M., Platz, E., Schneider, A., Wiethoff, A. J., Yu, X., Ngo, D., Svensson, E. C., Tsougos, E., Ho, C. Y., O’Donnell, C. J., et al. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2026.103237 · Cited by 1
Lumish, H. S., Sewanan, L. R., Liang, L. W., Hasegawa, K., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10618-x · Cited by 1
Tomidokoro, D., Mori, K., Yamamoto, M., Isono, M., Takano, K., Okazaki, A. I., Arakawa, R., Takeuchi, F., Hara, H., Hiroi, Y., et al. (2025) · International Heart Journal · doi:10.1536/ihj.24-667 · Cited by 1
Lozano-Paredes, D., Bote-Curiel, L., Molina, M. S., Bielza, C., Gimeno, J. R., Muñoz-Romero, S., Gimeno-Blanes, F.-J., Larrañaga, P., & Rojo‐Álvarez, J. L. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3572833 · Cited by 1
Chumakova, A., Vlasov, I. N., Filatova, E. V., Klass, A. L., Lysenko, A., Игоревич, С. Г., Shadrina, M. I., & Slominsky, P. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-03226-x · Cited by 1
Younas, A., Qadri, M., Ijlal, A., Khan, T., Pirzada, L., Kumari, V., Mubbashir, A., Singh, P. K., Sherwani, M. R. K., Noor, R., et al. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003436 · Cited by 1
Wang, R., He, Y., Ma, W., Xu, J., Zhong, Q., & Huang, C. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13597 · Cited by 1
Aficamten in the treatment of obstructive hypertrophic cardiomyopathy
Saleh, D., Eskandari, M., & Choudhury, L. (2025) · Future Cardiology · doi:10.1080/14796678.2025.2521183 · Cited by 2
Targeting steroid receptor RNA activator as a novel therapeutic strategy for myocardial hypertrophy
Qian, W., Liu, Z., Zhang, W., Yang, L., Zhang, Y., Liu, W., Tao, L., Xu, B., Sheng, L., & Shen, X. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117121 · Cited by 1
Role of Perturbations of Epigenetic Processes in Cardiac Hypertrophy and Fibrotic Scarring
Duvey, B. K., Sharma, D., Mittal, V., & Sharma, A. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x354902250708134633 · Cited by 2
Gupta, M. D., Kumar, B., Kunal, S., Sharma, V., Girish, M. P., Bansal, A., Batra, V., Goyal, D., Mahajan, B., Gupta, P., et al. (2025) · Indian Heart Journal · doi:10.1016/j.ihj.2025.07.004 · Cited by 1
Cardiac Hypertrophy: A Comprehensive Review from Prenatal Life to Young Adulthood
Avesani, M., Pomiato, E., Moscatelli, S., Sabatino, J., Borrelli, N., Luedke, L., Sarro, R. D., Pavesi, S., Pelaia, G., Mastellone, C., et al. (2025) · Children · doi:10.3390/children12080989 · Cited by 1
The Complex Puzzle of Hypertrophic Phenotype: A Practical Approach for the Clinician
Félix, A. D. S., Barberato, S. H., de Melo, M. D. T., Rosa, S. A., & Cardim, N. M. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240529i · Cited by 1
Heart Failure with Supranormal Ejection Fraction: A Female-Predominant Syndrome
Garg, R., & Prakash, P. (2025) · Indian Journal of Cardiovascular Disease in Women · doi:10.25259/ijcdw_109_2024 · Cited by 1
Relationship between genotype and clinical phenotype of hypertrophic cardiomyopathy
Zhang, L., Wang, B., Wang, J., Zhao, J. W., & Liu, L. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i8.107847 · Cited by 1
Role of Angiotensin Receptor Type I and Type II in the Development of Common Cardiac Problems
Hota, T., Sengupta, M., & Chatterjee, A. (2025) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_44_25 · Cited by 1
Precision Medicine in Cardiomyopathy: Advances and Future Directions
Mehdi, M., Verma, S., Mir, B. A., Verma, S., Rizvi, A. A., Ansari, A. I., Abbas, M., & Mahdi, F. (2025) · Clinical Genetics · doi:10.1111/cge.70072 · Cited by 1
Obstructive hypertrophic cardiomyopathy: pathophysiology and diagnosis
Antunes, M. M., Viegas, J., Ferreira, V. V., Thomas, B., & Rosa, S. A. (2025) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-025-02052-0 · Cited by 1
Efficient Installation of Heterozygous Mutations in Human Pluripotent Stem Cells Using Prime Editing
Suter, A., Graham, A. N., Kuah, J. Y., Crisologo, J., Gunatilake, C., Sourris, K., See, M., Rossello, F. J., Ramialison, M., Vlahos, K., et al. (2025) · The CRISPR Journal · doi:10.1177/25731599251380122 · Cited by 1
Buehning, F., Lerchner, T., Vogel, J. K., Kolk, L., Vogel, L., Seuthe, K., Ferdinandy, P., Mahabadi, A. A., Rassaf, T., & Michel, L. (2025) · Open Heart · doi:10.1136/openhrt-2025-003611 · Cited by 1
The Pathogenic Role of the DNA Double-Stranded Breaks in Hereditary Cardiomyopathies
Marian, A. J. (2025) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.08.006 · Cited by 1
Self-citationSystemic Metabolic Rewiring in a Mouse Model of Left Ventricular Hypertrophy
Schmidt, A. V., Thambidurai, T., D’Annibale, O., Bharathi, S. S., Wood, T. C., Goetzman, E. S., & Stelzer, J. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010111 · Cited by 1
Yang, T., Zhang, Z., Huang, S., Cui, M., Liu, S., Ding, M., Gu, W., Yang, B., & Zheng, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110249 · Cited by 1
Liu, C., Wen, W., & Zhang, Z. (2025) · Human Gene · doi:10.1016/j.humgen.2025.201504 · Cited by 1
Goyal, G., Debnath, A., Pal, A. K., Taleuzzaman, M., Nagarajana, K., & Kumar, V. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202502217 · Cited by 1
Alimohamed, M. Z., Kiula, A. H., Fundikira, L. S., Letara, N., Mayala, H. A., Sijmons, R. H., Jongbloed, J. D. H., Hershberger, R. E., Williams, S. M., Asselbergs, F. W., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01244-4 · Cited by 2
Li, S.-G., Wei, C., Su, D., Cheng, C., Qin, S., Ye, B., & Pang, Y. (2025) · Journal of International Medical Research · doi:10.1177/03000605251399040 · Cited by 1
Khaliq, I., Solanki, A., Kinno, M., Volgman, A. S., & Oktay, A. A. (2025) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2025.103249 · Cited by 1
Zheng, L., Lin, L., Wu, Z., Chen, S., Weng, C., Huang, J., Xie, M., Huang, J., & Chen, J. (2026) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s553380 · Cited by 1
Leyva, C. Z. M., Arroyo‐Rodríguez, C., Padilla-Islas, L. A., Hernández, F. A. M., Figueroa-Sauceda, S. R., & Zazueta-Armenta, V. (2026) · Archives of Medical Research · doi:10.1016/j.arcmed.2025.103362 · Cited by 1
Marwaha, K., Mody, B. P., Holland, N. A., Lane, M., Shoemake, B. D., Singh, N., & Mody, F. V. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00500.2025 · Cited by 1
Badr, A., Suppah, M., Awad, K., Abbas, M. T., Abdullah, H. A., Arsanjani, R., Ayoub, C., & Alsidawi, S. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.12.014 · Cited by 1
Zhang, Y., Qin, F., Guan, Y. F., Wang, J., Pu, L., Xia, Y., Zhang, C., Wang, D., Wu, X., Zhang, M., et al. (2025) · EP Europace · doi:10.1093/eurheartj/ehaf784.2588 · Cited by 1
Lin, Y., Hou, S., Lin, J., Zhang, T., Wu, B., Wu, Q., Qiu, S., Chen, J., Chen, D., & Huang, J. (2026) · Cardiology · doi:10.1159/000550829 · Cited by 1
Pregnancy Management and Outcomes with Hypertrophic Cardiomyopathy
Mehta, A., Schumacher, S., Bhansali, R., Kwapong, Y. A., Kim, Y. J., Adebowale, O. N., Vaught, A. “. J., Awais, Z., Sheikh, F. H., Michos, E. D., et al. (2026) · CJC Open · doi:10.1016/j.cjco.2026.02.007 · Cited by 1
Ong, K., Garceau, P., Crean, A. M., Moeller, A., Kolman, L., Corriveau, S., Brellier, F., Wong, C., & Ward, M. R. (2026) · CJC Open · doi:10.1016/j.cjco.2026.02.012 · Cited by 1
Multidisciplinary management of patients with hypertrophic cardiomyopathy
Rudenko, K. V., Danchenko, P. A., Rzhanyi, M., Chyzhevska, O. O., Bei, A. O., & Kovalyova, O. M. (2026) · Ukrainian Journal of Cardiology · doi:10.31928/2664-4479-2026.1.7585 · Cited by 1
Ni, H., Liang, F., Huo, H., Feng, X., & He, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1701776 · Cited by 1
Li, R., Wang, B., Shan, B., Sun, M., Ta, S., Zhao, J., Kang, N., Yang, F., Yuan, Y., Li, X., et al. (2026) · Metabolomics · doi:10.1007/s11306-026-02412-w · Cited by 1
Heyde syndrome secondary to hypertrophic obstructive cardiomyopathy: a case report
Castellanos-Maldonado, A., Canales‐Azcona, G. A., Martínez-Arroyo, J. L., Maldonado-Valdéz, M., & Ibarra‐Sifuentes, H. R. (2026) · The Egyptian Heart Journal · doi:10.1186/s43044-026-00727-6 · Cited by 1
Mahmoud, A., Awad, K., Sheashaa, H., Mohammed, A., Farina, J., Pereyra, M., Scalia, I. G., Hafez, A. H., Senjab, A., Ibrahim, R., et al. (2026) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2026.100756 · Cited by 1
Proteomic research in clinical samples of cardiovascular diseases
Liang, Y., Chaurembo, A. I., Chanda, F., Mayamba, B. S., Tian, M., Huang, Z.-F., Xing, N., & Lin, H. (2026) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2026.100253 · Cited by 1
Carella, M. C., Dicorato, M. M., Basile, P., Dentamaro, I., Santoro, D., Carulli, E., Latorre, M. D., Urgesi, E., Monitillo, F., Resta, N., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062327 · Cited by 1
Yang, L., Dai, H., & rong, Y. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1807582 · Cited by 2
Eraky, A. M., Mokhtar, Y., Grabau, G. M., Khan, A., JAROSZ, M., Wright, A., Grounds, M., & Kennedy, K. (2026) · Pathophysiology · doi:10.3390/pathophysiology33020027 · Cited by 1
McMillan, S. N., Pitts, J. R. T., Barua, B., Winkelmann, D. A., & Scarff, C. A. (2026) · Science Advances · doi:10.1126/sciadv.aea9335 · Cited by 10
Gene Therapy for Cardiomyopathy: Tools, Targets, and Trials
Agarwal, R. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.013361 · Cited by 1
Prognostic Value of the Hemodynamic Gain Index in Patients With Hypertrophic Cardiomyopathy
Vanhentenrijk, S., Chaikijurajai, T., Engelman, T., Grodin, J. L., Finet, J. E., Smedira, N. G., Desai, M. Y., & Tang, W. H. W. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.04.069 · Cited by 1
Amin, A. M., Shehada, W., Elgebaly, M., Ayman, D., Ibrahim, M., Abdelazeem, B., & Felpel, K. D. (2026) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2026.2667666 · Cited by 1
Costantino, J., Ballatore, F., Porcelli, D., Romani, B., Campoli, M., Zuccaro, L. M., Marchionni, G., Alfarano, M., Costantino, S., & Chimenti, C. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16060287 · Cited by 2
Syntabulin promotes heart failure by enhancing SR–mitochondria tethering and impairing mitofission
Li, Y., Sun, Z., Duan, H., Wu, M., Yi, J., Wang, G., Liu, W., Zhang, C., Cheng, W., Li, J. W., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag139 · Cited by 1
Metadata
- Authors
- Marian, A. J., & Braunwald, E.
- Affiliations
- Brigham and Women's Hospital (US)
- From the Center for Cardiovascular Genetics, Institute of Molecular Medicine, Department of Medicine, University of Texas Health Sciences Center at Houston (A.J.M.); Texas Heart Institute, Houston (A.J.M.); and TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (E.B.).
- ORCID
- Marian, Ali J.
- Venue
- Circulation Research
- Published
- 2017-09-15
- Volume
- 121
- Issue
- 7
- Pages
- 749-770
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC5654557
- OpenAlex
- W2756203218
- Cited by
- 1,403
- References
- 252
- Citations by year
- 2026: 175 · 2025: 226 · 2024: 219 · 2023: 199 · 2022: 153 · 2021: 174 · 2020: 103 · 2019: 83 · 2018: 61 · 2017: 6
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL088498, R01HL132401)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- hypertrophic cardiomyopathy, left ventricular hypertrophy, left ventricular outflow tract obstruction, sudden cardiac death, non-sustained ventricular tachycardia, syncope, cardioverter-defibrillator implantation, atrial fibrillation, sarcomere gene mutations, MYH7, MYBPC3, genetic testing, phenocopy, storage diseases, left ventricular diastolic dysfunction, interstitial fibrosis, molecular pathogenesis
- MeSH terms
- Animals, Biopsy, Cardiomyopathy, Dilated, DNA Mutational Analysis, Genetic Markers, Humans, Mutation, Myocardium, Phenotype, Predictive Value of Tests, Prognosis, Risk Factors, Ventricular Function, Left, Risk Assessment, Genetic Predisposition to Disease, Molecular Diagnostic Techniques, Cardiac Imaging Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
